Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...

The US Food and Drug Administration (FDA) has approved the first blood test for diagnosing Alzheimer’s disease.1 The test, called Lumipulse, was granted breakthrough device approval and is designed ...

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...